| 3B Blackbio DX Ltd | Industry : (Healthcare) | |
|---|---|---|
|
BSE Code : 532067 |
NSE Symbol : 3BBLACKBIO |
P/E(TTM) : 21.00 |
|
ISIN Demat : INE994E01018 |
Div & Yield% : 0.41 |
EPS(TTM) : 57.46 |
|
Book Value(₹) : 371.72 |
Market Cap(₹Cr) : 1,035.54 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 24.63 | 24.38 | 27.91 | 20.36 | 23.02 | 23.43 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 24.63 | 24.38 | 27.91 | 20.36 | 23.02 | 23.43 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.30 | 4.63 | 3.91 | 4.31 | 4.91 | 3.01 |
| Total Income | 25.93 | 29.01 | 31.82 | 24.67 | 27.93 | 26.44 |
| Total Expenditure | 13.35 | 9.91 | 12.07 | 8.77 | 13.56 | 8.46 |
| PBIDT | 12.59 | 19.10 | 19.75 | 15.90 | 14.37 | 17.98 |
| Interest | 0.00 | 0.02 | 0.01 | 0.01 | 0.03 | 0.02 |
| PBDT | 12.58 | 19.08 | 19.74 | 15.89 | 14.34 | 17.95 |
| Depreciation | 0.29 | 0.22 | 0.22 | 0.22 | 0.20 | 0.22 |
| Tax | 3.96 | 4.40 | 4.58 | 3.22 | 3.38 | 4.28 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.89 | 0.00 | 0.00 | 0.00 | 1.52 | 0.00 |
| Reported Profit After Tax | 7.45 | 14.46 | 14.94 | 12.46 | 9.24 | 13.45 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 7.45 | 14.46 | 14.94 | 12.46 | 9.24 | 13.45 |
| EPS (Unit Curr.) | 8.69 | 16.88 | 17.44 | 14.54 | 10.79 | 15.70 |
| EPS (Adj) (Unit Curr.) | 8.69 | 16.88 | 17.44 | 14.54 | 10.79 | 15.70 |
| Calculated EPS (Unit Curr.) | 8.69 | 16.88 | 17.44 | 14.54 | 10.79 | 15.70 |
| Calculated EPS (Adj) (Unit Curr.) | 8.69 | 16.88 | 17.44 | 14.54 | 10.79 | 15.70 |
| Calculated EPS (Ann.) (Unit Curr.) | 34.76 | 67.50 | 69.75 | 58.17 | 43.15 | 62.78 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 34.76 | 67.50 | 69.75 | 58.17 | 43.15 | 62.78 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 50.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 8.57 | 8.57 | 8.57 | 8.57 | 8.57 | 8.57 |
| Reserve & Surplus | 264.22 | 264.22 | 264.22 | 264.22 | 219.21 | 219.21 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 51.12 | 78.34 | 70.76 | 78.09 | 62.42 | 76.74 |
| PBDTM(%) | 51.08 | 78.26 | 70.73 | 78.05 | 62.29 | 76.61 |
| PATM(%) | 30.25 | 59.31 | 53.53 | 61.20 | 40.14 | 57.41 |
